DCF — BALTIMORE WASHINGTON MEDICAL CENTER
Enterprise Value: $-566.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-566.6M
Enterprise Value
$-182.6M
PV of Cash Flows
$-384.0M
PV of Terminal Value
$-618.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $453.5M | $-33.5M | -7.0% | $-52.7M | $-47.9M |
| Year 2 | $467.1M | $-29.8M | -6.0% | $-49.6M | $-41.0M |
| Year 3 | $481.1M | $-25.9M | -5.0% | $-46.3M | $-34.8M |
| Year 4 | $495.5M | $-24.2M | -5.0% | $-45.2M | $-30.9M |
| Year 5 | $510.4M | $-23.7M | -5.0% | $-45.3M | $-28.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-566.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$440.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0788405038002954
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5